Clinical Trial Update: Safety and Efficacy of Autologous SVF Cells in Treating Patients With Osteoarthritis [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating autologous SVF cells for safety and efficacy in osteoarthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• Autologous SVF cells

Snippet

Sponsor: Shanghai East Hospital | Conditions: Osteoarthritis | Phase 1, Phase 2 | Status: COMPLETED